| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Feb―16 |
Efficacy and safety of Toujie Quwen Granules in patients infected with SARS-CoV-2: A prospective cohort study of 156 cases |
Qihua Xu, Xinyue Zhang, Sanqi Huang, Linghua Li, Feng Li, Wei Liu, et al. (+4) Kunzhou Ling, Jialong Guan, Xinghua Tan, Luping Lin |
| 2 |
[GO] |
2026―Feb―11 |
Retrospective cohort study on Shufeng Jiedu granules for SARS-CoV-2 infection: Real-world evidence from multicenter outpatient clinics in a predominantly caucasian population |
Thomas Friedemann, Uta Knierim, Zhang Wei, Sven Schröder |
| 3 |
[GO] |
2025―Sep―04 |
Qingfei Paidu Granules for SARS-CoV-2 Omicron variant infection in children: A randomized controlled trial |
Jijun Li, Hongliang Dong, Mingyu Tang, Jilei Lin, Lan Li, Yan Ma, et al. (+2) Nannan Shi, Jian Gao |
| 4 |
[GO] |
2025―Apr―25 |
Shufeng Jiedu Granule against mild COVID-19: Protocol of the randomized, double-blind, placebo-controlled, multi-center heal-COVID phase III study |
Li Yang, Thomas Friedemann, Jun Pan, Xiangyu Li, Fuxiang Wang, Yuanlong Lin, et al. (+4) Qiang Zhu, Sven Schröder, Qingsong Liu, Hongzhou Lu |
| 5 |
[GO] |
2023―Dec―13 |
Anemoside B4 inhibits SARS-CoV-2 replication in vitro and in vivo |
Mingyue Xiao, Ronghua Luo, Qinghua Liang, Honglv Jiang, Yanli Liu, Guoqiang Xu, et al. (+4) Hongwei Gao, Yongtang Zheng, Qiongming Xu, Shilin Yang |
| 6 |
[GO] |
2023―Mar―08 |
New insights for infection mechanism and potential targets of COVID-19: Three Chinese patent medicines and three Chinese medicine formulas as promising therapeutic approaches |
Kexin Jia, Yijie Li, Tiegang Liu, Xiaohong Gu, Xiaojiaoyang Li |
| 7 |
[GO] |
2022―Mar―31 |
Exploration of hanshi zufei prescription for treatment of COVID-19 based on network pharmacology |
Xinrui Li, Zishuai Wen, Mingdong Si, Yuxin Jia, Huixian Liu, Yuguang Zheng, Donglai Ma |
| 8 |
[GO] |
2022―Feb―09 |
Identifying absorbable bioactive constituents of yupingfeng powder acting on COVID-19 through integration of UPLC-Q/TOF-MS and network pharmacology analysis |
Linyan Wang, Zhongyan Du, Yang Guan, Bo Wang, Yanling Pei, Lizong Zhang, Mingsun Fang |
| 9 |
[GO] |
2021―Oct―13 |
Analysis on oral medication rules of traditional Chinese medicine prescriptions for prevention of COVID-19 |
Dong-yang Wu, Zhong-shang Xia, Xiao-tao Hou, Er-wei Hao, Jin-ling Xie, Jing-yan Liang, et al. (+3) Qiu-ming Liang, Zheng-cai Du, Jia-gang Deng |
| 10 |
[GO] |
2021―Oct―01 |
Analysis on application law of dampness-removing chinese medicine in treatment of coronavirus disease 2019 |
Er-wei Hao, Zi-xia Su, Yan-ling Gong, Zheng-cai Du, Xue Yang, Chun-tao Huang, et al. (+2) Xiao-tao Hou, Jia-gang Deng |
| 11 |
[GO] |
2021―Jun―24 |
Dual inhibition of COVID-19 spike glycoprotein and main protease 3CLpro by Withanone from Withania somnifera |
Vishal Shivalingappa Patil, Vrushabh B. Hupparage, Ajay P. Malgi, Sanjay Ĥ. Deshpande, Sathgowda A. Patil, Shamanad P. Mallapur |
| 12 |
[GO] |
2020―Jul―09 |
Traditional Chinese medicine played a crucial role in battling COVID-19 |
De-an Guo |
| 13 |
[GO] |
2020―Jun―02 |
Carry forward advantages of traditional medicines in prevention and control of outbreak of COVID-19 pandemic |
Jia-gang Deng, Xiao-tao Hou, Tie-jun Zhang, Gang Bai, Er-wei Hao, Justin Jang Hann Chu, et al. (+5) Jintanaporn Wattanathorn, Panee Sirisa-ard, Ch'ng Soo Ee, John Low, Chang-xiao Liu |
| 14 |
[GO] |
2020―May―05 |
Traditional Chinese medicine contributes to the treatment of COVID-19 patients |
Liang Liu |
| 15 |
[GO] |
2020―Mar―31 |
Pay attention to situation of SARS-CoV-2 and TCM advantages in treatment of novel coronavirus infection |
Chang-xiao Liu |
|
